AcquisitionsApr 15, 2026, 07:41 AM
Tilray Acquires Lyphe Group, Expands UK Medical Cannabis Platform
AI Summary
Tilray Brands announced the acquisition of Lyphe Group, a leading UK-based medical cannabis clinic and digital pharmacy platform. This strategic move expands Tilray Medical's footprint in the UK, strengthening its vertically integrated medical ecosystem by combining clinical services, patient access, and pharmaceutical distribution. The acquisition is expected to be accretive in 2027 and is part of Tilray's broader global growth strategy across healthcare, cannabis, and beverages.
Key Highlights
- Tilray acquired Lyphe Group, a UK medical cannabis clinic and digital pharmacy platform.
- Lyphe Dispensary has dispensed approximately 150,000 units to date.
- Lyphe Clinic has treated over 16,000 patients to date.
- The acquisition is expected to be accretive in 2027.
- Establishes Tilray's first fully vertically integrated, patient-centric medical platform.